Cannabis Community Consumption Medical Research Science Wellness

Early data suggest medicinal cannabis could treat prostate cancer

Early data suggests medicinal cannabis could kill prostate cancer. (Image: Getty Images)

PROSTATE cancer is the most common form of cancer in men. Every year thousands get diagnosed with a condition that rarely presents symptoms in its early phases. Now new results suggest medicinal cannabis could be used as a treatment.

According to Cancer Research UK: “One in two people will develop cancer at some point in their lives.” That’s 50 percent of the population. Almost everyone in the UK knows someone who has been affected by, is being treated for, or has died from cancer. Such is its widespread effect that earlier this year the Government launched its 10-year War on Cancer. The aim of this initiative is to find new treatments that will help beat back cancer and save lives.

Just like in other fields of war, new technologies will have to be developed and new avenues walked down to find new treatments.

Medicinal cannabis could be one of those avenues, in fact it could become the Government’s unexpected armament in its War on Cancer.

Data from a UK based company, Apollon Formularies, has found that medicinal cannabis can kill prostate cancer cells.

In a statement it said: “Medicinal cannabis formulations were shown to be effective in killing both hormone-resistant and hormone sensitive prostate cancer cells in 3D cell cultures in third party independent laboratory testing.”

Doctor Stephen Barnhill, CEO of Apollon, noted: “Cannabinoids have been seen to exert ‘antitumor’ effects by a number of different means, including killing cancer cells directly as well as inhibiting cell growth and tumour metastasis.”

Although these results were conducted in a laboratory setting, they add to a growing body of evidence suggesting cannabis could have a positive impact on cancer and therefore a role in future treatments.

Cannabis Cancer research is playing catch up after years of stigmatisation that has held back research projects and trials.

As well as Apollon Formularies’ research, the Universities of Birmingham and Leeds are running a trial into whether a form of medicinal cannabis known as Sativex could be used to treat brain tumours.

To Read The Rest Of This Article By Christopher Sharp on Express UK

Published: March 21, 2022

Forget High Grade Marijuana, Consumers Just Want Cheap Weed
Ordering cannabis in L.A. is now as easy as booking an Uber
Year End Number of California’s Legal Cannabis Marketplace

Leave Your Reply